by The Uromigos
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Language
🇺🇲
Publishing Since
2/11/2020
Email Addresses
1 available
Phone Numbers
0 available
April 21, 2025
This episode explores the rapid growth of antibody-drug conjugate clinical drug development within China's pharmaceutical industry.
April 14, 2025
Urologist Dr. Dingwei Ye and Dr. Yao Zhu discuss the surge of GU clinical trials in China's drug development industry with host Dr. Kevin McVary
April 11, 2025
Urologist Dr. Alicia Morgans and oncologist Dr. Chuck Ryan discuss their new podcast with host
Sam and Karine
Professor Declan Murphy & Dr Renu Eapen
Vinay Prasad, MD MPH
Ark Media
Hidden Brain, Shankar Vedantam
The Times of Israel
Harvard Business Review
Freakonomics Radio + Stitcher
The Free Press
NPR
TED
Medscape
Oncology Brothers
American Society of Clinical Oncology (ASCO)
NPR
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.